ArticleJournal of atherosclerosis and thrombosis2024

Cardiovascular Adverse Events Associated with Tumor Necrosis Factor-Alpha Inhibitors: A Real-World Pharmacovigilance Analysis.

Junlong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.